Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Available items only

Title Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer [electronic resource].

Imprint

[Rockville, Md. : U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999]

Connect to
Connect to http://purl.access.gpo.gov/GPO/LPS48106

Location	Call No.	OPAC Message	Status
Axe Federal Documents Online	HE 20.6524:4/SUM.	---	Available

Series	Evidence report/technology assessment. Summary ; no. 4
	AHCPR publication ; no. 99-E011
	AHCPR pub. ; no. 99-E 011.
System Details	Mode of access via the AHCPR web site.
Note	Title from title screen (viewed on Apr. 29, 2004).
	"January 1999."
	"The full evidence report from which this summary was taken was prepared by the Evaluation Technology Center, an AHCPR Evidence-based Practice Center of the Blue Cross and Blue Shield Association, Chicago, Illinois, under contract no. 290-97-0015."
Subject	Prostate -- Cancer -- Hormone therapy.
	Antiandrogens -- Therapeutic use.
	Androgen Antagonists -- therapeutic use.
	Cost-Benefit Analysis.
	Gonadorelin -- antagonists & inhibitors.
	Outcome Assessment (Health Care)
	Prostatic Neoplasms -- drug therapy.
	Randomized Controlled Trials.
Added Author	United States. Agency for Health Care Policy and Research.
	Blue Cross and Blue Shield Association. Evaluation Technology Center.
Other Form:	Relative effectiveness and cost-effectiveness of methods of andogen suppression in the treatment of advanced prostatic cancer [6] p. (OCoLC)43871810
Gpo Item No.	0491-B-31 (online)
Sudoc No.	HE 20.6524:4/SUM.